Compile Data Set for Download or QSAR
Report error Found 40 Enz. Inhib. hit(s) with all data for entry = 50048249
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210127(CHEMBL3884851)
Affinity DataIC50: 2nMAssay Description:Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210072(CHEMBL3884830)
Affinity DataIC50: 2.40nMAssay Description:Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210075(CHEMBL3883788)
Affinity DataIC50: 4.80nMAssay Description:Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 42nMAssay Description:Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210074(CHEMBL3883423)
Affinity DataIC50: 153nMAssay Description:Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210129(CHEMBL3885334)
Affinity DataIC50: 1.21E+3nMAssay Description:Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210130(CHEMBL3885037)
Affinity DataIC50: 1.57E+3nMAssay Description:Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor XI(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210127(CHEMBL3884851)
Affinity DataIC50: 3.61E+3nMAssay Description:Inhibition of factor 11a (unknown origin) using S-2366 as substrate incubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210076(CHEMBL3884030)
Affinity DataIC50: 8.31E+3nMAssay Description:Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasminogen(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210074(CHEMBL3883423)
Affinity DataIC50: 9.97E+3nMAssay Description:Inhibition of Lys-plasmin (unknown origin) using Tosyl-Gly-Pro-Lys-4-nitranilide as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor XI(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210075(CHEMBL3883788)
Affinity DataIC50: 1.17E+4nMAssay Description:Inhibition of factor 11a (unknown origin) using S-2366 as substrate incubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor XI(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210074(CHEMBL3883423)
Affinity DataIC50: 1.27E+4nMAssay Description:Inhibition of factor 11a (unknown origin) using S-2366 as substrate incubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasminogen(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210075(CHEMBL3883788)
Affinity DataIC50: 2.14E+4nMAssay Description:Inhibition of Lys-plasmin (unknown origin) using Tosyl-Gly-Pro-Lys-4-nitranilide as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor XI(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 4.09E+4nMAssay Description:Inhibition of factor 11a (unknown origin) using S-2366 as substrate incubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210077(CHEMBL3883550)
Affinity DataIC50: 5.32E+4nMAssay Description:Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor XI(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210072(CHEMBL3884830)
Affinity DataIC50: 1.06E+5nMAssay Description:Inhibition of factor 11a (unknown origin) using S-2366 as substrate incubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210074(CHEMBL3883423)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of tPA (unknown origin) using Methylsulfonyl-D-Phe-Gly-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210075(CHEMBL3883788)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of tPA (unknown origin) using Methylsulfonyl-D-Phe-Gly-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor XII(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of factor 12a (unknown origin) using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210075(CHEMBL3883788)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of factor 10a (unknown origin) using N-Z-D-Arg-Gly-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasminogen(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210127(CHEMBL3884851)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of Lys-plasmin (unknown origin) using Tosyl-Gly-Pro-Lys-4-nitranilide as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor XII(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210074(CHEMBL3883423)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of factor 12a (unknown origin) using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of tPA (unknown origin) using Methylsulfonyl-D-Phe-Gly-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of factor 10a (unknown origin) using N-Z-D-Arg-Gly-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetProthrombin(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210075(CHEMBL3883788)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of alpha-thrombin (unknown origin) using D-Phe-Pip-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetProthrombin(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210074(CHEMBL3883423)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of alpha-thrombin (unknown origin) using D-Phe-Pip-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210074(CHEMBL3883423)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of factor 10a (unknown origin) using N-Z-D-Arg-Gly-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasminogen(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of Lys-plasmin (unknown origin) using Tosyl-Gly-Pro-Lys-4-nitranilide as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetProthrombin(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210127(CHEMBL3884851)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of alpha-thrombin (unknown origin) using D-Phe-Pip-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor XII(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210127(CHEMBL3884851)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of factor 12a (unknown origin) using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetProthrombin(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210073(CHEMBL3883461)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of alpha-thrombin (unknown origin) using D-Phe-Pip-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210127(CHEMBL3884851)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of tPA (unknown origin) using Methylsulfonyl-D-Phe-Gly-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor XII(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210075(CHEMBL3883788)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of factor 12a (unknown origin) using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210127(CHEMBL3884851)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of factor 10a (unknown origin) using N-Z-D-Arg-Gly-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor XII(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210072(CHEMBL3884830)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of factor 12a (unknown origin) using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210072(CHEMBL3884830)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of factor 10a (unknown origin) using N-Z-D-Arg-Gly-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetProthrombin(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210072(CHEMBL3884830)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of alpha-thrombin (unknown origin) using D-Phe-Pip-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210072(CHEMBL3884830)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of tPA (unknown origin) using Methylsulfonyl-D-Phe-Gly-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasminogen(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210072(CHEMBL3884830)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of Lys-plasmin (unknown origin) using Tosyl-Gly-Pro-Lys-4-nitranilide as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

Curated by ChEMBL
LigandPNGBDBM50210128(CHEMBL3884218)
Affinity DataIC50: 3.00E+6nMAssay Description:Inhibition of human plasma kallikrein using D-Pro-Phe-Arg-pNA as substrate preincubated for 30 mins followed by substrate additionMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/7/2018
Entry Details Article
PubMed